Canada is located in the northern part of the American continent. It extends from the Atlantic Ocean in the east to the Pacific Ocean in the west and northward into the Arctic Ocean, spanning over 9.9 million square kilometres,
Canada is the world's second-largest country by total area and its common border with the United States is the longest land border in the world.
|Pharmaceutical business environment||- The main growth drivers for the pharmaceutical industry are Canada’s academic research institutes, hospitals, government subsidies, economic and political stability and the proximity to the USA. In addition, the country offers competitive costs for pharmaceutical research and production.
- The government (especially in Quebec and Ontario) strongly supports the pharmaceutical industry.
- The world economic crisis has affected Canadian pharmaceutical manufacturing.
|Size||- USD 23,2 billion (2009)|
|Development||- Funding issues will continue to exert pressure on the healthcare system, given democraphic developments (average age 39.9 years).|
|Obstacles, e.g political regulation of the market||- Intellectual property rights are less strictly regulated, representing a disadvantage for research-driven companies.|
|The Canadian market for prescription medicines and over-the-counter medications||- The prescription medicine market generated turnover of more than USD 22 billion in 2010 and grew by 6.3 % between 2005 and 2010 (IMS)|